Terug
Dagbereik
€ 4,17
€ 4,25
52-Weeksbereik
€ 3,78
€ 5,00
Volume
1.200
50D / 200D Gem.
€ 4,33
/
€ 4,45
Vorige Slotkoers
€ 4,17
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,1 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | -9,2 | 3,8 |
| Net Margin % | -14,4 | 3,9 |
| Rev Growth 5Y % | 2,4 | 10,0 |
| D/E | 0,8 | 0,2 |
Belangrijkste Punten
Revenue grew 2,39% annually over 5 years — modest growth
Earnings declined -186,42% over the past year
Negative free cash flow of -15,37B
PEG of 0,10 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 25,25%
Groei
Revenue Growth (5Y)
2,39%
Revenue (1Y)-22,86%
Earnings (1Y)-186,42%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-9,22%
ROIC-5,86%
Net Margin-14,39%
Op. Margin-20,11%
Veiligheid
Debt / Equity
0,81
Current Ratio1,16
Interest Coverage-42,90
Waardering
P/E Ratio
-0,11
P/B Ratio0,01
EV/EBITDAN/A
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -22,86% | Revenue Growth (3Y) | -1,87% |
| Earnings Growth (1Y) | -186,42% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 2,39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33,07B | Net Income (TTM) | -4,76B |
| ROE | -9,22% | ROA | -4,54% |
| Gross Margin | 65,73% | Operating Margin | -20,11% |
| Net Margin | -14,39% | Free Cash Flow (TTM) | -15,37B |
| ROIC | -5,86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,81 | Current Ratio | 1,16 |
| Interest Coverage | -42,90 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | -0,11 | P/B Ratio | 0,01 |
| P/S Ratio | 0,02 | PEG Ratio | 0,10 |
| EV/EBITDA | N/A | Dividend Yield | 0,03% |
| Market Cap | 508,67M | Enterprise Value | 25,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33,07B | 42,87B | 34,34B | 51,08B | 30,09B |
| Net Income | -4,76B | 5,51B | 3,77B | 14,51B | 6,89B |
| EPS (Diluted) | -38,43 | 43,92 | 30,22 | 116,79 | 55,52 |
| Gross Profit | 21,74B | 31,25B | 25,46B | 40,62B | 22,27B |
| Operating Income | -6,65B | 7,53B | 4,98B | 19,93B | 8,27B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 104,86B | 102,23B | 94,94B | 97,13B | 73,78B |
| Total Liabilities | 57,42B | 45,75B | 42,53B | 46,05B | 35,23B |
| Shareholders' Equity | 47,04B | 56,18B | 52,16B | 50,88B | 38,38B |
| Total Debt | 38,11B | 23,30B | 22,80B | 18,10B | 18,10B |
| Cash & Equivalents | 13,20B | 18,76B | 13,28B | 30,73B | 26,26B |
| Current Assets | 51,06B | 57,58B | 47,80B | 62,19B | 48,55B |
| Current Liabilities | 43,99B | 30,14B | 35,76B | 42,05B | 29,03B |